Emerging Therapies Interactive Webcast Now Available!


Emerging Therapies: From Microscope to Marketplace Interactive Webcast
Now Available for Viewing!
 
The Parkinson's Action Network (PAN) invites you to watch the Emerging Therapies:  From Microscope to Marketplace Interactive Webcast archive online.  On June 24, leading experts in the field of research joined PAN at Georgetown University for a panel discussion on the drug development pipeline.  This insightful discussion provided participants with a better understanding of how research is moved through the pipeline and ultimately into the hands of patients in the form of new therapies and drugs.  The panel consisted of:

Howard Federoff, M.D., Ph.D.
Executive Vice President for Health Sciences and
Executive Dean of the School of Medicine, Georgetown University -- Moderator

James P. Bennett, Jr., M.D., Ph.D.
Chair, Department of Neurology and Founding Director of the
Virginia Commonwealth University Parkinson's Disease and
Movement Disorders Multidisciplinary Research and Clinical Center

Story C. Landis, Ph.D.
Director, National Institute of Neurological Disorders and Stroke,
National Institutes of Health

Raymond T. Bartus, Ph.D.
Executive Vice President and Chief Scientific Officer, Ceregene, Inc.

Jackie Hunt Christensen
PAN Minnesota State Coordinator and Clinical Trial Participant

Janet Woodcock, M.D.
Director, Center for Drug Evaluation and Research, Food and Drug Administration

The Webcast archive is available now and throughout the year for viewing at your convenience.  We encourage you to watch the presentation and learn about this vital issue.  The drug development pipeline is hugely important to those hoping for new treatments and cures.  The discussion was not specific to Parkinson's disease and is applicable to clinical research generally.

The lively panel discussion generated far more questions than the panelists were able to respond to.  As a way to address these questions, PAN has created a discussion page where a selection of questions from the Webcast is posted.  We are encouraging researchers and clinicians to take this opportunity to respond to these questions and for others to post new questions arising from this Webcast.

Click here to watch the Emerging Therapies Interactive Webcast.  To learn more about PAN and our programs, please visit our Web site.

 
PAN is grateful to the supporters of the Emerging Therapies Webcast:

This program is made possible by a conference support grant awarded from and administered by the Telemedicine & Advanced Technology Research Center (TATRC) of the U.S. Army Medical Research & Materiel Command (USAMRMC), Award # W81XWH-10-1-0361.

With additional contributions from: